Searchable abstracts of presentations at key conferences in endocrinology

ea0049gp175 | Pituitary | ECE2017

Resistance to somatostatin analogues is associated with GSTP1 gene methylation and AHR rs2066853 variant in acromegaly patients

Ferrau Francesco , Romeo Petronilla Daniela , Puglisi Soraya , Ragonese Marta , Spagnolo Federica , Ientile Riccardo , Picerno Isa Anna Maria , Curro Monica , Visalli Giuseppa , Alibrandi Angela , Cannavo Salvatore

Evidences suggest that environmental contaminants exposure and/or the impairment of intracellular xenobiotic metabolizing system could affect pituitary pathophysiology. Glutathione-S-transferase-P1 (GSTP1) gene encodes for an enzyme that is involved in cellular detoxification mechanisms. GSTP1 altered activity or expression has been reported in some tumours.We aimed to assess the GSTP1 gene promoter methylation status in acromegaly patients and its contr...

ea0070aep611 | Pituitary and Neuroendocrinology | ECE2020

Effects of different therapeutic approaches on cardiovascular risk in patients with acromegaly: Results of a multicentric study

Reimondo Giuseppe , Spagnolo Federica , Puglisi Soraya , Lombardi Stocchetti Benedetta , Ragonese Marta , Ceccato Filippo , Ferraù Francesco , Berchialla Paola , Carla Scaroni , Cannavò Salvatore , Terzolo Massimo

The association between acromegaly and increased cardiovascular morbidity and mortality is widely recognised. The aim of this retrospective multicentric study is to evaluate the impact of different therapeutic approaches on the progression of cardiovascular risk (CVR) in acromegalic patients. At diagnosis and last follow up (follow up time of 13 ± 8 years),we assessed BMI, blood pressure, glycaemic and lipid profile, GH and IGF1 levels in 199 patients with acromegaly (116...